Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A42590 | 34091928 | Hepatology | Familial Hypobetalipoproteinemia: An Underrecognized Cause of Lean NASH. | 2021 | Details |
| A42591 | 34089736 | Gastroenterology | Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few. | 2021 | Details |
| A42592 | 34082043 | Biochimie | Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential. | 2021 | Details |
| A42593 | 34080232 | Immunol Cell Biol | Zone defence - the gut microbiota position macrophages for optimal liver protection. | 2021 | Details |
| A42594 | 34078036 | Minerva Gastroenterol (Torino) | Role of triglycerides to high-density lipoprotein cholesterol ratio in non-alcoholic fatty liver disease progression. | 2021 | Details |
| A42595 | 34075641 | J Magn Reson Imaging | Editorial for "In Vivo Magnetic Resonance Spectroscopy of Hyperpolarized [1-13 C]Pyruvate in a Guinea Pig Model of Life-Long Western Diet Consumption and Non-Alcoholic Fatty Liver Disease Development". | 2021 | Details |
| A42596 | 34074837 | Am J Gastroenterol | Response to Ianiro et al. | 2021 | Details |
| A42597 | 34074836 | Am J Gastroenterol | Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better? | 2021 | Details |
| A42598 | 34070749 | Int J Mol Sci | Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis. | 2021 | Details |
| A42599 | 34058408 | Clin Gastroenterol Hepatol | Sugar-sweetened Beverages Are Associated With Increased Liver Stiffness and Steatosis Among Apparently Healthy Adults in the United States. | 2021 | Details |
| A42600 | 34056077 | Transplant Direct | Lose Weight to Donate: Development of a Program to Optimize Potential Donors With Hepatic Steatosis or Obesity for Living Liver Donation. | 2021 | Details |
| A42601 | 34049381 | J Clin Gastroenterol | Statins and Cancer Mortality in NAFLD: Is it Too Early to Rejoice? | 2021 | Details |
| A42602 | 34048861 | J Hepatol | Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients. | 2021 | Details |
| A42603 | 34046984 | Hepatol Res | Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade. | 2021 | Details |
| A42604 | 34046909 | Med J Aust | Non-alcoholic fatty liver disease: raising awareness of a looming public health problem. | 2021 | Details |
| A42605 | 34045218 | Drug Metab Dispos | Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes. | 2021 | Details |
| A42606 | 34035780 | Gastroenterol Hepatol (N Y) | Lean Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42607 | 34035697 | Gastroenterol Hepatol (N Y) | Smoking and Liver Disease. | 2020 | Details |
| A42608 | 34033517 | Scand J Gastroenterol | NAFLD cirrhosis in Sweden. | 2021 | Details |
| A42609 | 34033033 | MMW Fortschr Med | 2021 | Details | |
| A42610 | 34024056 | Clin Mol Hepatol | An analysis of polygenic risk scores for non-alcoholic fatty liver disease. | 2021 | Details |
| A42611 | 34023388 | J Biol Chem | Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice. | 2021 | Details |
| A42612 | 34021223 | Sci Rep | Author Correction: Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. | 2021 | Details |
| A42613 | 34019644 | J Clin Endocrinol Metab | Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? | 2021 | Details |
| A42614 | 34015974 | Expert Rev Clin Pharmacol | Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. | 2021 | Details |
| A42615 | 34015351 | Lancet Gastroenterol Hepatol | Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA. | 2021 | Details |
| A42616 | 34015269 | Cell Metab | TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis. | 2021 | Details |
| A42617 | 34011630 | Sci Transl Med | ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity. | 2021 | Details |
| A42618 | 34011622 | BMJ Open Gastroenterol | From adolescent PCOS to adult MAFLD: opposing effects of randomised interventions. | 2021 | Details |
| A42619 | 34002475 | Liver Int | A call to action for fatty liver disease. | 2021 | Details |
| A42620 | 33989632 | Metabolism | Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: Is it time to give the emperor a statin robe? | 2021 | Details |
| A42621 | 33987426 | Ann Transl Med | It's all about the spaces between cells: role of extracellular matrix in liver fibrosis. | 2021 | Details |
| A42622 | 33986456 | Int J Obes (Lond) | Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. | 2021 | Details |
| A42623 | 33985820 | J Hepatol | FXR agonists for NASH: How are they different and what difference do they make? | 2021 | Details |
| A42624 | 33983128 | Interact J Med Res | Relevance of Anthropometric Measurements in a Multiethnic Obesity Cohort: Observational Study. | 2021 | Details |
| A42625 | 33981216 | Front Pharmacol | Analysis of Time Course and Dose Effect From Metformin on Body Mass Index in Children and Adolescents. | 2021 | Details |
| A42626 | 33980691 | Diabetes | Genetic Evidence for Different Adiposity Phenotypes and Their Opposing Influences on Ectopic Fat and Risk of Cardiometabolic Disease. | 2021 | Details |
| A42627 | 33980244 | BMC Complement Med Ther | Correction to: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. | 2021 | Details |
| A42628 | 33967796 | Front Pharmacol | Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory. | 2021 | Details |
| A42629 | 33964851 | Am J Clin Nutr | Metabolic risk factors, genetic predisposition, and risk of severe liver disease in Chinese: a prospective study of 0.5 million people. | 2021 | Details |
| A42630 | 33961704 | Aliment Pharmacol Ther | Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? | 2021 | Details |
| A42631 | 33961702 | Aliment Pharmacol Ther | Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' reply. | 2021 | Details |
| A42632 | 33960005 | Hepatology | The Glucagon-Like Peptide-1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A42633 | 33956487 | Biotechniques | Secure and optimized detection of PNPLA3 rs738409 genotype by an improved PCR-restriction fragment length polymorphism method. | 2021 | Details |
| A42634 | 33953469 | Proc (Bayl Univ Med Cent) | Persistent lactic acidosis in the Mauriac syndrome in type 1 diabetes mellitus. | 2021 | Details |
| A42635 | 33951228 | NMR Biomed | Hydration and glycogen affect T1 relaxation times of liver tissue. | 2021 | Details |
| A42636 | 33948024 | Nat Rev Gastroenterol Hepatol | T cells in NASH and liver cancer: pathology and immunotherapy. | 2021 | Details |
| A42637 | 33939148 | Dig Dis Sci | Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42638 | 33933727 | Clin Nutr | Gender and gut microbiota composition determine hepatic bile acid, metabolic and inflammatory response to a single fast-food meal in healthy adults. | 2021 | Details |
| A42639 | 33932057 | Transpl Int | Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! | 2021 | Details |
| A42640 | 33930552 | Clin Gastroenterol Hepatol | Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals. | 2021 | Details |
| A42641 | 33925340 | Molecules | The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review. | 2021 | Details |
| A42642 | 33919641 | Diagnostics (Basel) | Associations between Pre-Bariatric High-Sensitivity C-Reactive Protein and Post-Surgery Outcomes. | 2021 | Details |
| A42643 | 33916086 | Int J Mol Sci | Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice. | 2021 | Details |
| A42644 | 33913073 | Obes Surg | Non-Invasive Markers in Non-Alcoholic Fatty Liver Disease: Reliability Is Variable According to BMI Status. | 2021 | Details |
| A42646 | 33901501 | Metabolism | Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward. | 2021 | Details |
| A42647 | 33901304 | Hepatology | The Importance of Glycemic Equipoise in NASH. | 2021 | Details |
| A42648 | 33892192 | Clin Gastroenterol Hepatol | Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: Enough Data to be Considered Effective? | 2021 | Details |
| A42649 | 33892008 | J Hepatol | Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience. | 2021 | Details |
| A42650 | 33890231 | Hepatol Int | Correction to: Targeting the ileal bile salt transporter in the treatment of non‑alcoholic fatty liver disease. | 2021 | Details |
| A42651 | 33882196 | Adv Healthc Mater | 2D Gadolinium Oxide Nanoplates as T1 Magnetic Resonance Imaging Contrast Agents. | 2021 | Details |
| A42652 | 33880982 | Expert Opin Pharmacother | What considerations are there for the pharmacotherapeutic management of nonalcoholic steatohepatitis? | 2021 | Details |
| A42653 | 33880928 | J Am Heart Assoc | Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation. | 2021 | Details |
| A42654 | 33869980 | J Endocr Soc | Removal of Epididymal Visceral Adipose Tissue Prevents Obesity-Induced Multi-organ Insulin Resistance in Male Mice. | 2021 | Details |
| A42655 | 33868668 | Clin Liver Dis (Hoboken) | Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies? | 2021 | Details |
| A42656 | 33868667 | Clin Liver Dis (Hoboken) | Pharmacological, Endoscopic, Metabolic, and Surgical Procedures for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42657 | 33868665 | Clin Liver Dis (Hoboken) | Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42658 | 33868663 | Clin Liver Dis (Hoboken) | Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42659 | 33867388 | Intern Med | Gastroesophageal Varices and Hyperplastic Nodules of the Liver in a Patient with Anorexia Nervosa. | 2021 | Details |
| A42660 | 33864034 | Nat Rev Cancer | T cell drivers in NASH-HCC. | 2021 | Details |
| A42661 | 33862038 | J Hepatol | Characterizing bacterial infections in acute-on-chronic liver failure among patients with cirrhosis from nonalcoholic steatohepatitis. | 2021 | Details |
| A42662 | 33861024 | J Dtsch Dermatol Ges | Psoriasis and non-alcoholic fatty liver disease. | 2021 | Details |
| A42663 | 33856704 | J Periodontol | Food restriction reduces hepatic alterations associated with experimental periodontitis. | 2021 | Details |
| A42664 | 33856175 | Am Fam Physician | Updated Statistics for Liver Biopsy Risk. | 2021 | Details |
| A42665 | 33856174 | Am Fam Physician | NAFLD in Children and Adolescents. | 2021 | Details |
| A42666 | 33849008 | J Innate Immun | Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease. | 2021 | Details |
| A42667 | 33847628 | Medicine (Baltimore) | Global research status of gastroenterology and hepatology: A bibliometrics study. | 2021 | Details |
| A42668 | 33847529 | Am Surg | Complex Abdominal Wall Reconstruction in Neutropenic Patients. | 2021 | Details |
| A42669 | 33847140 | J Am Heart Assoc | The Liver and the Cardiovascular System: Two of a Kind? | 2021 | Details |
| A42670 | 33846557 | Pediatr Res | Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease. | 2021 | Details |
| A42671 | 33833375 | Sci Rep | Author Correction: Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. | 2021 | Details |
| A42672 | 33827290 | Angiology | The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42673 | 33826778 | Hepatology | Therapeutic Potential of G Protein-Coupled Receptors Against Nonalcoholic Steatohepatitis. | 2021 | Details |
| A42674 | 33826777 | Hepatology | New Glance at the Role of TM6SF2 in Lipid Metabolism and Liver Cancer. | 2021 | Details |
| A42675 | 33824670 | J Res Med Sci | The effect of trans-palmitoleic acid on cell viability and sirtuin 1 gene expression in hepatocytes and the activity of peroxisome-proliferator-activated receptor-alpha. | 2020 | Details |
| A42676 | 33824256 | J Hypertens | Nonalcoholic fatty liver and left ventricular remodelling: now the prospective evidence. | 2021 | Details |
| A42677 | 33819416 | J Pediatr Endocrinol Metab | Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children. | 2021 | Details |
| A42678 | 33813071 | Clin Gastroenterol Hepatol | Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis. | 2021 | Details |
| A42679 | 33810823 | Poult Sci | Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken. | 2021 | Details |
| A42680 | 33809508 | Pharmaceuticals (Basel) | Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. | 2021 | Details |
| A42681 | 33798564 | Int J Radiat Oncol Biol Phys | A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma. | 2021 | Details |
| A42682 | 33796992 | Indian J Pediatr | Nonalcoholic Fatty Liver Disease and Subclinical Hypothyroidism in Obese Children. | 2021 | Details |
| A42683 | 33788408 | Liver Int | A new diagnostic criterion for sarcopenia: The fallout of lack of consensus. | 2021 | Details |
| A42684 | 33785558 | Gut | Long-term exposure to fine particulate matter and non-alcoholic fatty liver disease: a prospective cohort study. | 2021 | Details |
| A42685 | 33784425 | J Leukoc Biol | HMGB1: An overview of its roles in the pathogenesis of liver disease. | 2021 | Details |
| A42686 | 33776368 | World J Gastroenterol | Chronic renal dysfunction in cirrhosis: A new frontier in hepatology. | 2021 | Details |
| A42687 | 33775642 | Am J Med | Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease. | 2021 | Details |
| A42688 | 33771239 | Biomed Environ Sci | A Self-test Prediction Model to Determine the Probability Risk of Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A42690 | 33759592 | Angiology | AST to ALT Ratio and Peripheral Arterial Disease in a Hypertensive Population-Is There a Link? | 2021 | Details |
| A42691 | 33758643 | World J Diabetes | Progress on haptoglobin and metabolic diseases. | 2021 | Details |